9th August RNS re £1m subscription17 Aug 2021 19:41
Been racking my thoughts over this extract ...
For the purposes of Disclosure Guidance and Transparency rules .....re effectively the total # of sareum shares , may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the company under the DG + T Rules.
.....it says the proceeds are to progress the companys 1801 and 1802....as noted in the companys trading update of 25th May 21 the company is targeting the filing of a clinical trial approval for sdc 1801 in Q4 21....that's October!!
I've read up on DG and T rules. Especially Disclosure.
Imo I believe a director deal being made via a RNS. Given Q4 point!
You don't sheet on your own doorstep do you!
The trades the last week are as I suspected re 17th August submission. Happy with that.
I think if you have friends tell them to get in by atleast end of August. But they should DTOR
Best regards Steadydanny